PVS_volume changes, ΔPVS_volumes, for various radiation doses within each treatment period: 0M–3M(a), 3M–12M(b), and 12M–FollowUp(c). by Ruitian Song (11045127)

Subjects:

Univariate and Multivariate analysis of risk factors for nerve injury 90-days after TKA. by Rahul H. Jayaram (21463899)

Subjects:

The dataset for the paired model. by Ruitian Song (11045127)

Subjects:

Patient enrollment and inclusion information. by Ruitian Song (11045127)

Subjects:

Changes of PVS ratios and volumes for different treatment periods and different dose levels (HD: high dose, SD: standard dose, and RD: reduced dose). by Ruitian Song (11045127)

Subjects:

The dataset for the full model analysis. by Ruitian Song (11045127)

Subjects:

Mod is expressed throughout the larval CNS and is primarily nuclear. by Amalia S. Parra (4173004)

Subjects:

RT-qPCR Primer. by Dequan Wang (6007007)

Subjects:

Loss of Mod does not affect NB asymmetric cell division. by Amalia S. Parra (4173004)

Subjects:

CCND1 is a target gene of miR-1247-3p. by Dequan Wang (6007007)

Subjects:

Development of <i>Drosophila</i> Neuroblasts (NB). by Amalia S. Parra (4173004)

Subjects:

miR-1247-3p was downregulated in CRC resistant cells. by Dequan Wang (6007007)

Subjects:

miR-1247-3p plasmid. by Dequan Wang (6007007)

Subjects:

Aims, outcomes and main results of the included studies. by Mairena Sánchez-López (684092)

Subjects:

RNA-sequencing data screening for miR-1247-3p target genes. by Dequan Wang (6007007)

Subjects:

Dual luciferase primer. by Dequan Wang (6007007)

Subjects:

Differentially expressed genes following Mod knockdown. by Amalia S. Parra (4173004)

Subjects:

shCCND1 plasmid. by Dequan Wang (6007007)

Subjects:

Characteristics of the studies. by Mairena Sánchez-López (684092)

Subjects:

CCND1 promoted chemoresistance in CRC. by Dequan Wang (6007007)

Subjects: